Molecular Networks GmbH

What Molecular Networks GmbH does

Molecular Networks GmbH - Computerchemie, operating jointly with its U.S. subsidiary Altamira LLC under the MN-AM brand, develops and sells chemoinformatics software for chemical safety and risk assessment. Founded in 1997 and headquartered in Nuremberg, Germany with a U.S. office in Columbus, Ohio, the company builds two core product lines: ChemTunes·ToxGPS, a chemoinformatics platform paired with an expert-curated toxicity knowledge base that supports read-across workflows, point-of-departure estimation, and regulatory frameworks including ICH M7, REACH, TTC, and next-generation risk assessment; and CORINA Classic, a 3D molecular structure generator with documented performance for large-scale chemistry datasets. Adjacent offerings include CORINA Symphony (an advanced version integrating Cepos InSilico's EMPIRE semi-empirical quantum-mechanical parameter calculation) and a public COSMOS NG knowledge base. The company was acquired by Lhasa Limited in January 2025 and now operates as a wholly-owned subsidiary.

MN-AM serves pharmaceutical, chemical, biotechnology, and cosmetics enterprises alongside regulatory agencies such as the US FDA and US EPA. Its go-to-market combines enterprise field sales with a strong conference presence at SOT, EUROTOX, ASCCT, and SITOX, complemented by OEM/ISV integrations into BIOVIA's pipeline, Chemical Computing Group's Molecular Operating Environment, Inte:Ligand's ilib diverse library generator, and BioSolveIT's FlexX docking program. Named enterprise customers include L'Oréal, Unilever, Roche, and Procter & Gamble. Revenue is generated through quote-based annual software subscriptions for ChemTunes·ToxGPS and CORINA, with additional revenue likely from licensing royalties and scientific consulting.

The business model is enterprise software licensing on a subscription cadence with quote-based, non-public pricing. Revenue mechanics combine direct enterprise subscriptions, OEM/embedded royalties through integration partners, and grant-funded research collaborations with EU and U.S. agencies (COSMOS, ONTOX, FDA, EPA). The 11-50 employee headcount is small relative to enterprise customers' regulatory and R&D budgets, reflecting a high-value, specialty-tool vendor profile rather than a horizontal SaaS model.

Name

Molecular Networks GmbH

Legal name

Molecular Networks GmbH – Computerchemie

Website

https://mn-am.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Molecular Networks GmbH (MN-AM) develops chemoinformatics software, including the ChemTunes·ToxGPS toxicity platform and CORINA 3D structure generator, for chemical safety and risk assessment across pharmaceutical, chemical, biotechnology, and cosmetics industries and regulatory agencies.

Ownership category

akta.pro rank

Product category

Chemoinformatics Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Cheminformatics & Molecular Modeling / CADD (HLAGAJAE)

akta.pro secondary industry

In Silico / Computational Toxicology & PK/PD Modeling (HLAGAFAM)

Keywords

• Chemoinformatics software
• Computational toxicology
• Molecular modeling tools
• Chemical safety assessment
• 3D structure generation

Headquarters

HQ city

Erlangen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Licensing and Subscriptions: MN-AM provides software products including CORINA Classic and ChemTunes·ToxGPS to pharmaceutical, chemical, and biotechnology companies for computational toxicology and chemical safety assessment. Revenue is generated through software licensing, subscriptions, and potentially professional services for implementation and training.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Molecular Networks GmbH (MN-AM) develops and sells chemoinformatics software for chemical safety assessment, computational toxicology, and molecular modeling. Its core offerings are ChemTunes·ToxGPS, a chemoinformatics platform with an expert-reviewed toxicity knowledgebase for in silico prediction of human health endpoints and read-across workflows, and CORINA Classic, a 3D molecular structure generator used in big-data chemistry applications.

Product overview

MN-AM offers a suite of chemoinformatics software solutions for the chemical, biotechnology, and pharmaceutical industries. The product portfolio centers on two core commercial products: ChemTunes·ToxGPS (a chemoinformatics platform and toxicity knowledgebase for chemical safety and risk assessment) and CORINA Classic (a 3D structure generator). Additional offerings include CORINA Symphony (advanced version with quantum mechanical calculations) and the public COSMOS Next Generation platform. These tools provide capabilities spanning from 3D molecular structure generation to toxicity predictions, read-across workflows, and regulatory safety assessment support.

Differentiator

Problem solved

Functional benefit

Products and services

• ChemTunes·ToxGPS A unique chemoinformatics platform and toxicity knowledgebase supporting chemical safety and risk assessment of human health and regulatory-relevant endpoints. Provides expert-reviewed toxicity database, MoA-based in silico predictions, bioavailability data, POD bounds calculator, and read-across workflows for specific chemical domains. Used by pharmaceutical, chemical, and biotechnology companies for computational toxicology and regulatory safety assessment.
• CORINA Classic A fast, reliable, and robust 3D molecular structure generator with broad scope of application and covered chemical space, providing excellent performance for big-data chemistry applications. Used by computational chemists and life science researchers for 3D molecular structure generation.
• CORINA Symphony Advanced chemoinformatics application offering optional quantum mechanical parameter calculations based on the EMPIRE semi-empirical molecular orbital program from Cepos InSilico. Provides enhanced molecular modeling capabilities beyond CORINA Classic for users requiring quantum-mechanical descriptors.
• COSMOS Next Generation (COSMOS NG) Public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals, providing toxicity data and workflows for chemical safety assessment as the public version complementary to the commercial ChemTunes·ToxGPS platform.

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Lhasa LimitedcoreStrategic or Co-development PartnerAcquired by Lhasa Limited in January 2025. Lhasa is described as the leader in decision making software for in silico chemical safety. The acquisition brings together MN-AM's chemoinformatics platform with Lhasa's computational toxicology solutions.
• BIOVIA (Dassault Systèmes)coreTechnology or IntegrationMolecular Networks partners the Independent Software Vendor (ISV) Program of BIOVIA, distributing CORINA technology through BIOVIA's channel to their extensive customer base in pharmaceutical and chemical industries.
• Chemical Computing Group (CCG)coreTechnology or IntegrationSince version 2007.09, CCG's Molecular Operating Environment (MOE) provides an interface to seamlessly integrate CORINA, enabling computational chemists to use 3D structure generation within the MOE workflow.
• Biomax Informatics AGminorStrategic or Co-development PartnerStrategic partnership to effectively join bioinformatics and chemoinformatics into one stream of research, combining the strengths of both companies' technology platforms.
• BioSolveIT GmbHminorGTM or Marketing PartnerBioSolveIT and Molecular Networks collaborate for joint marketing on the North American market and for a seamless interface between BioSolveIT's premium docking program FlexX and CORINA.
• S-IN Soluzioni Informatiche SrlminorStrategic or Co-development PartnerCollaboration in providing services and consulting in computational toxicology in compliance with REACH and ICH M7 regulatory guidelines by sharing complementary state-of-the-art technology and expert knowledge.
• COSMOS ProjectcoreStrategic or Co-development PartnerEU FP7/Cosmetics Europe project where Altamira is the US partner and Molecular Networks is the EU partner. Contributed to the COSMOS NG public knowledge base for chemical safety assessment.
• US FDA (Center for Food Safety and Applied Research)coreStrategic or Co-development PartnerCollaboration partner for chemical safety assessment, including evaluation of FDA's chemical inventories for human health endpoints and support for FDA's CERES project.
• US EPA (National Center for Computational Toxicology)coreStrategic or Co-development PartnerCollaboration partner contributing to computational toxicology initiatives including ToxCast data analysis and development of chemoinformatics approaches.
• The Ohio State UniversitycoreStrategic or Co-development PartnerAcademic collaboration partner in the Department of Chemical and Biomolecular Engineering, working on translational safety assessment and DILI prediction tools.
• ACC Biocides PanelminorStrategic or Co-development PartnerPrevious research sponsor for Antimicrobial (AM) TTC Project, demonstrating applicability of TTC approach to evaluation of antimicrobial pesticides.
• ONTOX Project ConsortiumcoreStrategic or Co-development PartnerEuropean research project on safer chemicals using less animals. MN-AM contributes to developing novel in silico methods to predict toxicity of chemicals without animal testing.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mn-am

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Networks GmbH